THYROCARE.BO
THYROCARE.BO
INE594H01019
Thyrocare Technologies Limited
Loading chart...

Company Profile

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment engages in the selling of consumables used for collection, and promotion of pathology. The Imaging Services segment sells radio-pharmaceutical and consumables for reporting. The Others segment engages in the sale of glucometer and glucostrips under the brand name sugarscan. The company offers diagnostic and pathological services. The company was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.

Related stocks

METROPOLIS.NS
METROPOLIS.NS • India
METROPOLIS HEALTHCARE LTD
529.25 INR
1.13B USD 1Y +4.2%
VIJAYA.NS
VIJAYA.NS • India
VIJAYA DIAGNOSTIC CEN LTD
1,436.6 INR
1.53B USD 1Y +44.5%
SYNGENE.NS
SYNGENE.NS • India
SYNGENE INTERNATIONAL LTD
347.4 INR
1.44B USD 1Y -45.1%
603108.SS
603108.SS • China
SHANGHAI RUNDA MEDICAL TECHNOLO
9.97 CNY
901.98M USD 1Y -36.5%
SAILIFE.NS
SAILIFE.NS • India
SAI LIFE SCIENCES LIMITED
1,487.9 INR
3.27B USD 1Y +74.7%
4694.T
4694.T • Japan
BML INC
3,650 JPY
864.57M USD 1Y +1.2%
300463.SZ
300463.SZ • China
MAKER BIOTECHNOLOGY
9.58 CNY
866.78M USD 1Y -17%
300406.SZ
300406.SZ • China
BSBE
12.14 CNY
1.06B USD 1Y -9.7%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
38.2% p.a.
Max Drawdown (5Y)
-65.7%
Sharpe Ratio (5Y)
0.07
Beta Factor
0.45
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 45.3 (Elevated multiple compression risk)
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (38.2% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -71.0% in the extended horizon.
ende